கோட்டை இப் குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

IAM
The Long Read
Life sciences companies are frequently on the front line when it comes to being flexible on IP and pricing, says Ben Bourke of Womble Bond Dickinson. The most recent example of this is Moderna Therapeutics’ promise not to enforce patents relating to its approved covid-19 vaccine. Such a response makes sense and should be favoured over government-led initiatives to circumvent IP rights. Read more here
MONDAY 5th April
A look at Chinese companies’ semiconductor patent holdings suggests that their best bet for gaining globally relevant IP in the space is to acquire it. However, that leaves them with a big problem. Read more here ....

United States , Rock Creek , Bio Pharma , Tiffany Cunningham , Andrei Iancu , Thom Tillis , Ben Bourke , Supreme Court , Rock Creek Networks , Fortress Ip Group , Iam Global Patent Litigation , Us Senate , Argentum Pharmaceuticalsv Novartis Pharmaceuticals , Helsinn Group , Sun Patent , Womble Bond , Moderna Therapeutic , Western District , Argentum Pharmaceuticals , Intellectual Property Appellate Board , Bridgebio Pharma , ஒன்றுபட்டது மாநிலங்களில் , பாறை க்ரீக் , உயிர் பார்மா , டிஃப்பனி கன்னிங்ஹாம் , தோம் வரை ,